check_circleStudy Completed

Bayer Identifier:

17861

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2015-000082-31

EU CT Number:

Not Available
Relative bioavailability of rivaroxaban under different administration conditions

Trial purpose

Key Participants Requirements

Sex

Male

Age

18 - 55 Years
  • -

  • -

Trial summary

Enrollment Goal
16
Trial Dates
March 2015 - June 2015
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteer
Yes

Where to participate

StatusInstitutionLocation
Completed
Mannheim, 68167, Germany

Trial design

Single-dose, open-label, randomized, 5-way crossover study to compare different administration conditions of the oral suspension of rivaroxaban in healthy subjects
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
Randomized
Blinding
Open Label
Assignment
Crossover Assignment
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to Bayer Healthcare products.